Association between pulmonary artery pulsatility and mortality after implantation of left ventricular assist device.
Circulatory assist devices
Database
Haemodynamics
Heart failure
Left ventricular assist device
Ventricle, right
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
05 Apr 2024
05 Apr 2024
Historique:
revised:
10
01
2024
received:
01
12
2023
accepted:
18
01
2024
medline:
6
4
2024
pubmed:
6
4
2024
entrez:
6
4
2024
Statut:
aheadofprint
Résumé
Right ventricular failure after left ventricular assist device (LVAD) implantation is a major concern that remains challenging to predict. We sought to investigate the relationship between preoperative pulmonary artery pulsatility index (PAPi) and mortality after LVAD implantation. A retrospective analysis of the ASSIST-ICD multicentre registry allowed the assessment of PAPi before LVAD according to the formula [(systolic pulmonary artery pressure - diastolic pulmonary artery pressure)/central venous pressure]. The primary endpoint was survival at 3 months, according to the threshold value of PAPi determined by the receiver operating characteristic (ROC) curve. A multivariate analysis including demographic, echographic, haemodynamic, and biological variables was performed to identify predictive factors for 2 year mortality. One hundred seventeen patients were included from 2007 to 2021. The mean age was 58.45 years (±13.16), with 15.4% of women (sex ratio 5.5). A total of 53.4% were implanted as bridge to transplant and 43.1% as destination therapy. Post-operative right ventricular failure was observed in 57 patients (48.7%), with no significant difference between survivors and non-survivors at 1 month (odds ratio 1.59, P = 0.30). The median PAPi for the whole study population was 2.83 [interquartile range 1.63-4.69]. The threshold value of PAPi determined by the ROC curve was 2.84. Patients with PAPi ≥ 2.84 had a higher survival rate at 3 months [PAPi < 2.84: 58.1% [46.3-72.8%] vs. PAPi ≥ 2.84: 89.1% [81.1-97.7%], hazard ratio (HR) 0.08 [0.02-0.28], P < 0.01], with no significant difference after 3 months (HR 0.67 [0.17-2.67], P = 0.57). Other predictors of 2 year mortality were systemic hypertension (HR 4.22 [1.49-11.97], P < 0.01) and diabetes mellitus (HR 4.90 [1.83-13.14], P < 0.01). LVAD implantation as bridge to transplant (HR 0.18 [0.04-0.74], P = 0.02) and heart transplantation (HR 0.02 [0.00-0.18], P < 0.01) were associated with a higher survival rate at 2 years. Preoperative PAPi < 2.84 was associated with a higher risk of early mortality after LVAD implantation without impacting 2 year outcomes among survivors.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Mancini D, Colombo PC. Left ventricular assist devices. J Am Coll Cardiol 2015;65:2542‐2555. doi:10.1016/j.jacc.2015.04.039
WHO. Cardiovascular diseases (CVDs) [Internet]. 2019. Available from: https://www.who.int/news‐room/fact‐sheets/detail/cardiovascular‐diseases‐(cvds)
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 3 mai 2022 [cited 2 janv 2023] 2022;145: doi:10.1161/CIR.0000000000001063
Hanff TC, Birati EY. Left ventricular assist device as destination therapy: A state of the science and art of long‐term mechanical circulatory support. Curr Heart Fail Rep 2019;16:168‐179. doi:10.1007/s11897‐019‐00438‐x
Yuzefpolskaya M, Schroeder SE, Houston BA, Robinson MR, Gosev I, Reyentovich A, et al. The Society of Thoracic Surgeons Intermacs 2022 annual report: Focus on the 2018 heart transplant allocation system. Ann Thorac Surg 2023;115:311‐327. doi:10.1016/j.athoracsur.2022.11.023
Anselmi A, Galand V, Vincentelli A, Boule S, Dambrin C, Delmas C, et al. Current results of left ventricular assist device therapy in France: The ASSIST‐ICD registry. Eur J Cardiothorac Surg 2020;58:112‐120.
Hariri IM, Dardas T, Kanwar M, Cogswell R, Gosev I, Molina E, et al. Long‐term survival on LVAD support: Device complications and end‐organ dysfunction limit long‐term success. J Heart Lung Transplant 2022;41:161‐170. doi:10.1016/j.healun.2021.07.011
Brescia AA, Watt TMF, Pagani FD, Cascino TM, Zhang M, McCullough JS, et al. Assessment of mortality among durable left ventricular assist device recipients ineligible for clinical trials. JAMA Netw Open 2021;4:e2032865. doi:10.1001/jamanetworkopen.2020.32865
Rame JE, Pagani FD, Kiernan MS, Oliveira GH, Birati EY, Atluri P, et al. Evolution of late right heart failure with left ventricular assist devices and association with outcomes. J Am Coll Cardiol 2021;78:2294‐2308. doi:10.1016/j.jacc.2021.09.1362
Baumwol J, Macdonald PS, Keogh AM, Kotlyar E, Spratt P, Jansz P, et al. Right heart failure and “failure to thrive” after left ventricular assist device: Clinical predictors and outcomes. J Heart Lung Transplant 2011;S1053249811008680; doi:10.1016/j.healun.2011.03.006
Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous‐flow left ventricular assist device: Incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010;139:1316‐1324. doi:10.1016/j.jtcvs.2009.11.020
Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transplant 2015;34:1123‐1130. doi:10.1016/j.healun.2015.06.015
Dang N, Topkara V, Mercando M, Kay J, Kruger K, Aboodi M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006;25:1‐6. doi:10.1016/j.healun.2005.07.008
Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M, Kushwaha SS, et al. Prediction of right ventricular failure after ventricular assist device implant: Systematic review and meta‐analysis of observational studies: Meta‐analysis of right ventricular failure determinants after LVAD implant. Eur J Heart Fail 2017;19:926‐946. doi:10.1002/ejhf.733
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). Appendix A: Adverse event definitions: Adult and pediatric patients [Internet]. 2013 [cited 10 May 2022]. Available from: https://www.uab.edu/medicine/intermacs/images/version_6_1/Updated_IM_Adverse_Events_11_3_21.docx
Houston BA, Shah KB, Mehra MR, Tedford RJ. A new “twist” on right heart failure with left ventricular assist systems. J Heart Lung Transplant 2017;36:701‐707. doi:10.1016/j.healun.2017.03.014
Bravo CA, Navarro AG, Dhaliwal KK, Khorsandi M, Keenan JE, Mudigonda P, et al. Right heart failure after left ventricular assist device: From mechanisms to treatments. Front Cardiovasc Med 9:1023549.
Unsworth B, Casula RP, Kyriacou AA, Yadav H, Chukwuemeka A, Cherian A, et al. The right ventricular annular velocity reduction caused by coronary artery bypass graft surgery occurs at the moment of pericardial incision. Am Heart J 2010;159:314‐322. doi:10.1016/j.ahj.2009.11.013
Hayek S, Sims DB, Markham DW, Butler J, Kalogeropoulos AP. Assessment of right ventricular function in left ventricular assist device candidates. Circ: Cardiovascular Imag 2014;7:379‐389.
Haddad F, Denault AY, Couture P, Cartier R, Pellerin M, Levesque S, et al. Right ventricular myocardial performance index predicts perioperative mortality or circulatory failure in high‐risk valvular surgery. J Am Soc Echocardiogr 2007;20:1065‐1072. doi:10.1016/j.echo.2007.02.017
Denault AY, Haddad F, Jacobsohn E, Deschamps A. Perioperative right ventricular dysfunction. Curr Opin Anaesthesiol 2013;26:71‐81. doi:10.1097/ACO.0b013e32835b8be2
Morine KJ, Kiernan MS, Pham DT, Paruchuri V, Denofrio D, Kapur NK. Pulmonary artery pulsatility index is associated with right ventricular failure after left ventricular assist device surgery. J Card Fail 2016;22:110‐116. doi:10.1016/j.cardfail.2015.10.019
Essandoh M, Kumar N, Hussain N, Dalia AA, Wang D, Al‐Qudsi O, et al. Pulmonary artery pulsatility index as a predictor of right ventricular failure in left ventricular assist device recipients: A systematic review. J Heart Lung Transpl 2022;41:1114‐1123. doi:10.1016/j.healun.2022.04.007
Kang G, Ha R, Banerjee D. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation. J Heart Lung Transpl 2016;35:67‐73. doi:10.1016/j.healun.2015.06.009
Korabathina R, Heffernan KS, Paruchuri V, Patel AR, Mudd JO, Prutkin JM, et al. The pulmonary artery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction. Cathet Cardiovasc Intervent 2012;80:593‐600. doi:10.1002/ccd.23309
Kochav SM, Flores RJ, Truby LK, Topkara VK. Prognostic impact of pulmonary artery pulsatility index (PAPi) in patients with advanced heart failure: Insights from the ESCAPE trial. J Cardiac Fail 2018;24:453‐459. doi:10.1016/j.cardfail.2018.03.008
Kumar S, Rahman A, Josephs JS, Saeed O, Patel S, Murthy S, et al. Trend in pulmonary artery pulsatility index pre‐ to post‐LVAD implantation. J Heart Lung Transplant 2019;38:S357. doi:10.1016/j.healun.2019.01.908
Tehrani BN, Truesdell AG, Sherwood MW, Desai S, Tran HA, Epps KC, et al. Standardized team‐based care for cardiogenic shock. J Am Coll Cardiol 2019;73:1659‐1669. doi:10.1016/j.jacc.2018.12.084
Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008;117:1436‐1448. doi:10.1161/CIRCULATIONAHA.107.653576
Lim HS, Gustafsson F. Pulmonary artery pulsatility index: Physiological basis and clinical application. Eur J Heart Fail 2020;22:32‐38. doi:10.1002/ejhf.1679
Lim HS, Howell N, Ranasinghe A. The effect of left ventricular assist device therapy in patients with heart failure and mixed pulmonary hypertension. Int J Artif Organs 2017;40:67‐73. doi:10.5301/ijao.5000556
Masri SC, Tedford RJ, Colvin MM, Leary PJ, Cogswell R. Pulmonary arterial compliance improves rapidly after left ventricular assist device implantation. ASAIO J 2017;63:139‐143. doi:10.1097/MAT.0000000000000467
Mazimba S, Welch TS, Mwansa H, Breathett KK, Kennedy JLW, Mihalek AD, et al. Haemodynamically derived pulmonary artery pulsatility index predicts mortality in pulmonary arterial hypertension. Heart Lung Circ 2019;28:752‐760. doi:10.1016/j.hlc.2018.04.280
Rong LQ, Rahouma M, Neuburger PJ, Arguelles G, Emerson J, Mauer E, et al. Use of pulmonary artery pulsatility index in cardiac surgery. J Cardiothorac Vasc Anesth 2020;34:1220‐1225. doi:10.1053/j.jvca.2019.09.023
Osteresch R, Diehl K, Schmucker J, Ben Ammar A, Solyom O, Dierks P, et al. Prognostic impact of the pulmonary artery pulsatility index in patients with chronic heart failure and severe mitral regurgitation undergoing percutaneous edge‐to‐edge repair. Cardiology 2021;146:74‐84. doi:10.1159/000510283
Guven G, Brankovic M, Constantinescu AA, Brugts JJ, Hesselink DA, Akin S, et al. Preoperative right heart hemodynamics predict postoperative acute kidney injury after heart transplantation. Intensive Care Med 2018;44:588‐597. doi:10.1007/s00134‐018‐5159‐z
Molina EJ, Shah P, Kiernan MS, Cornwell WK, Copeland H, Takeda K, et al. The Society of Thoracic Surgeons Intermacs 2020 annual report. Ann Thorac Surg 2021;111:778‐792. doi:10.1016/j.athoracsur.2020.12.038
Bahl A, Qureshi B, Zhang K, Bravo C, Mahr C, Li S. Explainable machine learning analysis of right heart failure after left ventricular assist device implantation. ASAIO J 2023;69:417‐423. doi:10.1097/MAT.0000000000001843
Muslem R, Ong CS, Tomashitis B, Schultz J, Ramu B, Craig ML, et al. Pulmonary arterial elastance and INTERMACS‐defined right heart failure following left ventricular assist device. Circ Heart Fail 2019;12:e005923. doi:10.1161/CIRCHEARTFAILURE.119.005923
Isaza N, Gonzalez M, Saijo Y, Vega Brizneda M, Estep J, Starling RC, et al. Incremental value of global longitudinal strain to Michigan risk score and pulmonary artery pulsatility index in predicting right ventricular failure following left ventricular assist devices. Heart Lung Circ 2022;31:1110‐1118. doi:10.1016/j.hlc.2022.03.012
Kumar S, Derbala MH, Nguyen DT, Ferrall J, Cefalu M, Rivas‐Lasarte M, et al. A multi‐institutional retrospective analysis on impact of RV acute mechanical support timing after LVAD implantation on 1‐year mortality and predictors of RV acute mechanical support weaning. J Heart Lung Transplant 2022;41:244‐254. doi:10.1016/j.healun.2021.10.005